Trademark applications and grants for Mimetogen Pharmaceuticals Inc. Mimetogen Pharmaceuticals Inc has 1 trademark applications. The latest application filed is for "OPTIMIM"
Patent Application | Date |
---|---|
SOLUTION PHASE SYNTHESIS OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS 20210300966 - 17/337383 Rocchi; Sebastien ;   et al. | 2021-09-30 |
SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS 20190194251 - 16/184485 Rocchi; Sebastien ;   et al. | 2019-06-27 |
SOLUTION PHASE SYNTHESIS AND CRYSTALLIZATION OF BETA-TURN PEPTIDOMIMETIC CYCLIC SALTS 20170008923 - 15/205909 Rocchi; Sebastien ;   et al. | 2017-01-12 |
BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING DRY EYE 20160082072 - 14/858874 CUMBERLIDGE; Garth ;   et al. | 2016-03-24 |
BETA-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS FOR TREATING DRY EYE 20140274910 - 14/290845 CUMBERLIDGE; Garth ;   et al. | 2014-09-18 |
Mark Image Registration | Serial | Trademark Application Date |
---|---|
"OPTIMIM" 85487711 |
OPTIMIM 2011-12-05 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.